WhichRecall
Class IIIReported 2026-01-14

Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30

Recalled by Alembic Pharmaceuticals Limited

Reason for Recall

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Advertisement
Recall Number
D-0248-2026
Classification
Class III
Status
Ongoing
Category
drug
Initiated
2025-12-16
Reported
2026-01-14
Distribution
US Nationwide and PR.
Code Info
Lot# 2405003360, Exp Date: Jan 31, 2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement